ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,459.10
1.11%
US Tech 100
18,514.00
1.00%
Dow Jones
40,589.34
1.64%
Brent Oil
79.745
0.00%
Bitcoin
68,551.94
0.94%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE

  6. Bausch plus Lomb Corporation (BLCO) Quote

Bausch plus Lomb Corporation

Bausch plus Lomb Corporation (BLCO)

Bausch and Lomb Corporation
Bausch and Lomb Corporation
Bausch and Lomb Corporation
15.81
0.28
(1.80%)
Closed July 27 4:00PM
Delayed by 15 minutes
16.50
0.69
(4.36%)
After Hours: 7:40PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
16.50
Bid
-
Ask
-
Volume
416,870
15.36 Day's Range 15.81
13.16 52 Week Range 20.30
Market Cap
5.799B
Previous Close
15.53
Open
15.59
Last Trade
114
@
16.5
(formt)
Last Trade Time
Financial Volume
$ 6,500,626
VWAP
15.5939
Average Volume (3m)
503,386
Shares Outstanding
351,482,100
Dividend Yield
-
PE Ratio
-29.58
Earnings Per Share (EPS)
-0.74
Revenue
4.15B
Net Profit
-260M

About Bausch plus Lomb Corporation

Bausch & Lomb, headquartered in Laval, Quebec, Canada, is the fourth-largest vision care company by sales in the United States and the market leader in consumer vision care in India and China. The firm, which was previously a subsidiary under parent company Bausch Health, was spun off to become a pu... Bausch & Lomb, headquartered in Laval, Quebec, Canada, is the fourth-largest vision care company by sales in the United States and the market leader in consumer vision care in India and China. The firm, which was previously a subsidiary under parent company Bausch Health, was spun off to become a public company once again in May 2022. The firm reports in three segments-vision care and consumer (60% of revenue), surgical (20%), and ophthalmic pharmaceuticals (20%). The company is geographically diversified, with 48% of revenue in the Americas, 30% from EMEA, and 22% from Asia-Pacific countries. Show more

Sector
Offices Of Optometrists
Industry
Offices Of Optometrists
Headquarters
Toronto, Ontario, Can
Founded
1970
Bausch plus Lomb Corporation is listed in the Offices Of Optometrists sector of the New York Stock Exchange with ticker BLCO. The last closing price for Bausch plus Lomb was $15.53. Over the last year, Bausch plus Lomb shares have traded in a share price range of $ 13.16 to $ 20.30.

Bausch plus Lomb currently has 351,482,100 shares outstanding. The market capitalization of Bausch plus Lomb is $5.46 billion. Bausch plus Lomb has a price to earnings ratio (PE ratio) of -29.58.

BLCO Latest News

More News

Bausch + Lomb Will Release Second-Quarter 2024 Financial Results on July 31

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its second-quarter 2024 financial results on...

July 11 2024
Business Wire

Millions of Americans Experience Dry Eye Symptoms, Yet New National Survey Shows Sufferers Struggle to Find Relief

New Online Resource, KnowYourDryEye.com, Aims to Increase Awareness and Education Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see...

July 08 2024
Business Wire

Form 4 - Statement of changes in beneficial ownership of securities

June 18 2024
Edgar (US Regulatory)

Bausch + Lomb Announces Presentation of New Data at the European Dry Eye Society 2024 Congress

Events Include Symposium on Patient-Centric Approaches to Dry Eye, Highlighting Breakthroughs in Diagnosis, Treatment and Care Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye...

June 17 2024
Business Wire

Bausch + Lomb INFUSE® for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United States

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. introduction of Bausch + Lomb...

June 10 2024
Business Wire

Bausch + Lomb Launches Blink™ NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United States

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launch of Blink NutriTears, a...

June 03 2024
Business Wire

Form 8-K - Current report

May 29 2024
Edgar (US Regulatory)

Bausch + Lomb Announces 2024 Annual Meeting of Shareholder Results

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”), a leading global eye health company dedicated to helping people see better to live better, today announced the...

May 29 2024
Business Wire

Bausch + Lomb Announces Presentation of New Scientific Data and Evaluations Featuring Consumer, Vision Care and Pharmaceutical Products at Optometry’s Meeting®

15 ePosters and In-Person Presentations Will Include Clinical Data on Blink™ NutriTears® Supplement for Dry Eyes, Blink® Triple Care Lubricating Eye Drops and MIEBO® (Perfluorohexyloctane...

May 28 2024
Business Wire

Bausch + Lomb Receives Health Canada Approval for enVista® Envy™* Full Visual Range Intraocular Lens

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Health Canada has approved the enVista®...

May 28 2024
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.4-2.3668639053316.917.3214.05167872216.28959922CS
41.7511.864406779714.7517.4314.0575805516.06675005CS
122.4617.521367521414.0417.4313.5350338615.47717481CS
261.9413.324175824214.5617.69513.1649587615.38516796CS
52-3.22-16.328600405719.7220.313.1649356216.01340147CS
156-2-10.810810810818.521.9512.260662716.33034392CS
260-2-10.810810810818.521.9512.260662716.33034392CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WINTWindtree Therapeutics Inc
$ 8.24
(150.46%)
48.57M
BFIBurgerFi International Inc
$ 0.4206
(97.37%)
313.59M
NBSTWNewbury Street Acquisition Corporation
$ 0.1349
(92.71%)
122.1k
YIBOPlanet Image International Ltd
$ 2.915
(53.43%)
260.07k
CREVCarbon Revolution Public Ltd
$ 9.00
(45.87%)
8.06M
NMHINatures Miracle Holding Inc
$ 0.2035
(-48.06%)
7.69M
TANHTantech Holdings Ltd
$ 0.2585
(-47.23%)
6.75M
DXCMDexCom Inc
$ 64.00
(-40.66%)
53.92M
PSIGPS International Group Ltd
$ 1.42
(-31.40%)
716.26k
POAIPredictive Oncology Inc
$ 1.36
(-27.27%)
6.02M
SLNASelina Hospitality PLC
$ 0.0305
(-18.88%)
408.61M
BFIBurgerFi International Inc
$ 0.4206
(97.37%)
313.59M
NVDANVIDIA Corporation
$ 113.06
(0.69%)
293.33M
SQQQProShares UltraPro Short QQQ
$ 9.10
(-2.88%)
176.49M
SGMOSangamo Therapeutics Inc
$ 0.8612
(28.15%)
123.71M

BLCO Discussion

View Posts
Zilla Zilla 3 months ago
Good ER but stock dived down, bounced up and down again...Hit 13.64 and closed 13.74
So that golden cross might be off the table unless it pops tomorrow if BHC doesn't distribute in 2024...
👍️0
Zilla Zilla 3 months ago
Almost another year later and 88.7% of BLCO is still with BHC almost 2 years after the IPO just before the ER...
Currently BLCO is 14.79 with less than 5% short interest...10.5% Inst owned...
BHC is @ 8.71 72% inst/owned about 12% short interest...
Norwich lost in court recently and BHC had hit 11.46 a little before the verdict on a quick POP and it's been dropping ever since. Didn't break below the 200DMA of 8.30 but tested the 8.50's often...
👍️0
Zilla Zilla 3 months ago
BLCO @ 14.79 with ER next week...
200DMA 16.53
50DMA 15.89
Golden Cross may be heading our way...If the ER sends us up and BHC doesn't announce a distribution...
👍️0
Zilla Zilla 5 months ago
Good ER and more than a buck higher open it looks like. I sold too soon as always and also I sold a 100 calls so that's about 20,000 I would have gotten more had I held 1 day longer. Still got my 'core' of calls that are good til there end of the year but these results are really good. Stock should be fine moving forward until BHC shareholders get the BLCO shares and then it will probably sell off but recover and make new highs at some point. =)
👍️0
Zilla Zilla 5 months ago
Sold all 10,000 BLCO above 14.50 just a few cents higher than my cost after flipping so many times. Have good chunk of calls both ITM and not. Just felt I had WAY too much in one stock with all these M&A deals it seems like a 'top' is incoming. So as of now I'm about 20% in calls and 80% in cash... Was 15% cash and 85% invested this morning. Good luck tomorrow and the chart looks really good to run to 17's in the coming weeks as long as tomorrow doesn't surprise to the downside.
👍️0
Zilla Zilla 5 months ago
Yesterday BLCO hit 14.66. I sold a good chunk @ 14.50 even though I wanted to keep it but got it back today @14
Chart looking like a nice set up into and after earnings next week. We shall see but I've flipped enough times and lowered my average so I'm feeling good. If it tanks on news of BHC shareholders getting BLCO stock my BHC will rise/rocket and I can either hold that for the BLCO shares or trade them accordingly being I already have BLCO shares. Or buy the shares back into BHC and that works too. Stock too cheap down here under 15
👍️0
Zilla Zilla 6 months ago
Today BLCO made new 52 week low of 13.85 currently at 14 with BHC at 8....Something has changed between these two stocks. lol
I still think both are undervalued and stuck together. Needed to either give BHC shareholders the 80% BLCO shares or...Reverse Merge or buy back BLCO. At 14 for BLCO they could gobble it right back up and the spin at least let them pay down some debt when distressed the past year and a half.
BLCO at 14 feels like a spin of the 50.1% is coming this year but who knows...ER's should be this month and hopefully BOTH stocks rise up to new 52 week highs but you never know. lol
👍️0
Zilla Zilla 1 year ago
Today BLCO buys XIIDRA from NVS and makes new all time high of 21.95
BHC went up to 8.22 and closed at 8
So the future 'growth' will be the BLCO asset and getting 80% of the company in BHC shareholders hands. BHC is 7% short interest as BLCO is over 17 and stock is just above 20...
I think both are undervalued
👍️0
Zilla Zilla 1 year ago
1 year later not so much. lol Though 88.7% of BLCO is still with BHC over a year after the IPO...BS!
Currently about 18.50 for BLCO with 19% short interest and almost 13% Inst/own...
BHC I use to see under 10% short interest but I double taked when I saw 37.22% short interest (as of 5/31/23 and 66% Inst/own trading at 7.19 today. WTF?!? That's some SERIOUS Shorts...Also seems kind of fishy with the 5/17 judge ruling in BHC favor sending the stock from 6 to 9 in days...Only to have Norwich sue the FDA to overrule the courts news on 6/6/23 with the stock breaking below 8 the day before and then breaking below 7... I think a lawsuit and an investigation is in order.
👍️0
Zilla Zilla 2 years ago
Well now we will see what B&L can do away from BHC/VRX
👍️0
weedtrader420 weedtrader420 2 years ago
BLCO$ Cross Eyed Mary
👍️0
weedtrader420 weedtrader420 2 years ago
BLCO$
👍️0

Your Recent History

NYSE
BLCO
Bausch plus Lomb
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved